Skip to content

A randomized controlled trial of Selective Decongestive Devascularization Shunt of Gastrosplenic Region and Pericardial Devascularization with Splenectomy in the treatment of portal hypertension

A randomized controlled trial of SDDS-GSR and PCDV in the treatment of portal hypertension

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-08000041
Enrollment
Unknown
Registered
2008-01-23
Start date
2007-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal hypertension due to liver cirrhosis

Interventions

Group 1:SDDS-GSR operation
Group 2:PCDV operation

Sponsors

No.1 Hospital Affiliated to Wenzhou Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnostic Criteria: Decompensation Stage due to liver cirrhosis and Child A or B on Child-pugh grading system; 2. Anatomy Requirement: The diameters of splenic vein exceeding 1.0cm, and left renal vein exceeding 0.8cm detected by Doppler US or MRI of portal venous system. No thrombosis in portal system; no hepatofugal flow in portal vein.

Exclusion criteria

Exclusion criteria: 1. Undefined diagnosis; 2. Local anatomic condition is too poor to fit.

Design outcomes

Primary

MeasureTime frame
Incidence of serious complications;Blood dynamic indicators of post-operation;Difference between free portal vein pressure before operation and mesenteric area presure after operation;Quality of life after operation;

Secondary

MeasureTime frame
Blood transfusion requirement;Liver function;

Countries

China

Contacts

Public ContactQiyu Zhang
zqy80@163.com+86 0 13905775052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026